These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17591554)

  • 1. Synthesis and positron emission tomography studies of C-11-labeled isotopomers and metabolites of GTS-21, a partial alpha7 nicotinic cholinergic agonist drug.
    Kim SW; Ding YS; Alexoff D; Patel V; Logan J; Lin KS; Shea C; Muench L; Xu Y; Carter P; King P; Constanzo JR; Ciaccio JA; Fowler JS
    Nucl Med Biol; 2007 Jul; 34(5):541-51. PubMed ID: 17591554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxy metabolites of the Alzheimer's drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine dihydrochloride (GTS-21): their molecular properties, interactions with brain nicotinic receptors, and brain penetration.
    Kem WR; Mahnir VM; Prokai L; Papke RL; Cao X; LeFrancois S; Wildeboer K; Prokai-Tatrai K; Porter-Papke J; Soti F
    Mol Pharmacol; 2004 Jan; 65(1):56-67. PubMed ID: 14722237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evaluation of alpha7 nicotinic acetylcholine receptor agonists [11C]A-582941 and [11C]A-844606 in mice and conscious monkeys.
    Toyohara J; Ishiwata K; Sakata M; Wu J; Nishiyama S; Tsukada H; Hashimoto K
    PLoS One; 2010 Feb; 5(2):e8961. PubMed ID: 20126539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of new imaging agent for central nicotinic acetylcholine receptor α7 subtype.
    Ogawa M; Nishiyama S; Tsukada H; Hatano K; Fuchigami T; Yamaguchi H; Matsushima Y; Ito K; Magata Y
    Nucl Med Biol; 2010 Apr; 37(3):347-55. PubMed ID: 20346874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biodistribution of radiolabeled alpha 7 nicotinic acetylcholine receptor ligands.
    Pomper MG; Phillips E; Fan H; McCarthy DJ; Keith RA; Gordon JC; Scheffel U; Dannals RF; Musachio JL
    J Nucl Med; 2005 Feb; 46(2):326-34. PubMed ID: 15695794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and disposition of GTS-21, a novel drug for Alzheimer's disease.
    Azuma R; Komuro M; Korsch BH; Andre JC; Onnagawa O; Black SR; Mathews JM
    Xenobiotica; 1999 Jul; 29(7):747-62. PubMed ID: 10456692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21).
    Kem WR
    Behav Brain Res; 2000 Aug; 113(1-2):169-81. PubMed ID: 10942043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical and the first clinical studies on [11C]CHIBA-1001 for mapping alpha7 nicotinic receptors by positron emission tomography.
    Toyohara J; Sakata M; Wu J; Ishikawa M; Oda K; Ishii K; Iyo M; Hashimoto K; Ishiwata K
    Ann Nucl Med; 2009 May; 23(3):301-9. PubMed ID: 19337782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation in rats and primates of [11C]-mecamylamine, a potential nicotinic acetylcholine receptor radioligand for positron emission tomography.
    Sobrio F; Debruyne D; Dhilly M; Chazalviel L; Camsonne R; Kakiuchi T; Tsukada H; Barré L
    Neurochem Int; 2005 May; 46(6):479-88. PubMed ID: 15769550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and positron emission tomography studies of carbon-11-labeled imatinib (Gleevec).
    Kil KE; Ding YS; Lin KS; Alexoff D; Kim SW; Shea C; Xu Y; Muench L; Fowler JS
    Nucl Med Biol; 2007 Feb; 34(2):153-63. PubMed ID: 17307123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.
    Doll F; Dolci L; Valette H; Hinnen F; Vaufrey F; Guenther I; Fuseau C; Coulon C; Bottlaender M; Crouzel C
    J Med Chem; 1999 Jun; 42(12):2251-9. PubMed ID: 10377231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivatives of (-)-7-methyl-2-(5-(pyridinyl)pyridin-3-yl)-7-azabicyclo[2.2.1]heptane are potential ligands for positron emission tomography imaging of extrathalamic nicotinic acetylcholine receptors.
    Gao Y; Horti AG; Kuwabara H; Ravert HT; Hilton J; Holt DP; Kumar A; Alexander M; Endres CJ; Wong DF; Dannals RF
    J Med Chem; 2007 Aug; 50(16):3814-24. PubMed ID: 17629263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosynthesis and in vivo evaluation of two imidazopyridineacetamides, [(11)C]CB184 and [ (11)C]CB190, as a PET tracer for 18 kDa translocator protein: direct comparison with [ (11)C](R)-PK11195.
    Hatano K; Sekimata K; Yamada T; Abe J; Ito K; Ogawa M; Magata Y; Toyohara J; Ishiwata K; Biggio G; Serra M; Laquintana V; Denora N; Latrofa A; Trapani G; Liso G; Suzuki H; Sawada M; Nomura M; Toyama H
    Ann Nucl Med; 2015 May; 29(4):325-35. PubMed ID: 25616581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [
    Eberl S; Katsifis A; Peyronneau MA; Wen L; Henderson D; Loc'h C; Greguric I; Verschuer J; Pham T; Lam P; Mattner F; Mohamed A; Fulham MJ
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):296-307. PubMed ID: 27699720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis.
    Pavlov VA; Ochani M; Yang LH; Gallowitsch-Puerta M; Ochani K; Lin X; Levi J; Parrish WR; Rosas-Ballina M; Czura CJ; Larosa GJ; Miller EJ; Tracey KJ; Al-Abed Y
    Crit Care Med; 2007 Apr; 35(4):1139-44. PubMed ID: 17334244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-α production and lung injury.
    Kox M; Pompe JC; Peters E; Vaneker M; van der Laak JW; van der Hoeven JG; Scheffer GJ; Hoedemaekers CW; Pickkers P
    Br J Anaesth; 2011 Oct; 107(4):559-66. PubMed ID: 21771746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor.
    Mathews WB; Murugesan N; Xia J; Scheffel U; Hilton J; Ravert HT; Dannals RF; Szabo Z
    J Nucl Med; 2008 Sep; 49(9):1529-36. PubMed ID: 18703610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
    Chattopadhyay S; Xue B; Collins D; Pichika R; Bagnera R; Leslie FM; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    J Nucl Med; 2005 Jan; 46(1):130-40. PubMed ID: 15632043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-labeled styrylpyridines as PET agents for amyloid plaque imaging.
    Zhang W; Kung MP; Oya S; Hou C; Kung HF
    Nucl Med Biol; 2007 Jan; 34(1):89-97. PubMed ID: 17210465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vivo evaluation of [O-methyl-11C](2R,4R)-4-hydroxy-2-[2-[2-[2-(3-methoxy)phenyl]ethyl]phenoxy]ethyl-1-methylpyrrolidine as a 5-HT2A receptor PET ligand.
    Kumar JS; Prabhakaran J; Erlandsson K; Majo VJ; Simpson NR; Pratap M; Van Heertum RL; Mann JJ; Parsey RV
    Nucl Med Biol; 2006 May; 33(4):565-74. PubMed ID: 16720250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.